CannaPharmaRx, Inc.
corporate_fare Company Profile
CannaPharmaRx, Inc. (OTC:CPMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for CPMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for CPMD spans 10-Q.
Recent high-impact activity:
- CannaPharmaRx Q3: $32,037 Cash, $30.9M Working Capital Hole, $9.3M in Arrears
- CannaPharmaRx Q2 2026: Going Concern Doubt, $31M Working Capital Deficit, and Debt Defaults
- CannaPharmaRx Discloses Going Concern Doubt, Material Weakness, and Multiple Defaults
Financial Snapshot
Short Interest & Short Volume
On November 20, 2026, 70.6% of CPMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.